West Pharmaceutical Services | WST - Beneficio Operativo





Beneficio Operativo Cambio Fecha
Align Technology USD 191.32M 13.27M 2026-06
Baxter International USD 276M 210M 2026-06
Becton, Dickinson and Co. USD 627M 36M 2026-03
Cerus USD -1.45M 488K 2024-12
Charles River Laboratories USD 119.9M 44.08M 2026-03
Cooper Companies USD -31M 243.8M 2026-03
Dentsply International USD 32M 506M 2026-03
Haemonetics USD 67.4M 8.9M 2025-12
ICU Medical USD 26.09M 770K 2025-12
Insulet USD 122M 24.3M 2026-03
Integra LifeSciences USD 41.29M 29.82M 2026-06
IQVIA Holdings USD 2.6B 2.03B 2026-06
J&J USD 7.48B 860M 2026-06
Medtronic USD 2.09B 354M 2026-03
Merit Medical Systems USD 60.4M 16.25M 2026-06
Neogen USD 3.1M 6.4M 2026-03
OraSure Technologies USD -13.59M 2.13M 2025-12
Quidel USD -31.8M 5.5M 2026-03
Repligen USD 21.13M 1.15M 2026-06
Rockwell Medical USD 515K 1.84M 2024-06
Solventum Corp USD 85M 20M 2026-03
STAAR Surgical USD 17.4M 28.34M 2026-03
Terumo JPY 31.45B 12.43B 2026-03
Utah Medical Products USD 2.56M 124K 2026-03
West Pharmaceutical Services USD 179.1M 2M 2026-06